Kite Pharma, Inc. Total Liabilities and Equity
Kite Pharma, Inc. had Total Liabilities and Equity of $907.11 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2017-08-08
- 2017-06-30: Liabilities and Equity $907.11M.
- 2017-03-31: Liabilities and Equity $923.74M.
- 2016-12-31: Liabilities and Equity $524.30M.
- 2016-09-30: Liabilities and Equity $584.52M.
| Period end | Liabilities and Equity |
|---|---|
| 2017-06-30 | $907.11M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $923.74M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $524.30M 10-Q · filed 2017-08-08 |
| 2016-09-30 | $584.52M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $635.67M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $679.25M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $707.96M 10-K · filed 2017-02-28 |
| 2015-09-30 | $450.81M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $464.73M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $490.68M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $370.75M 10-K · filed 2016-02-29 |
| 2014-09-30 | $198.33M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $205.60M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $22.98M 10-K · filed 2015-03-26 |